Doctors hail 'pivotal moment' in breast cancer treatment as new drug is found to boost survival
Enhertu, a drug produced by AstraZeneca and Daiichi Sankyo, was found to extend survival by more than six months in patients with a form of advanced breast cancer compared to standard chemotherapy.
Source: dailymail.co.uk